Cronos Group Posts Fourth Straight Quarter Of Gross Losses In Q3 2020

Cronos Group (TSX: CRON) (NASDAQ: CRON) this morning reported its third quarter financial results for the period ended September 30, 2020. The company reported net revenues of $11.4 million for the period, along with a net income of $68.5 million, primarily a result of a gain on derivative liabilities with the firm actually posting negative gross margins for the fourth quarter in a row.

Despite the climb in net revenues of 14.9%, the company saw its cost of sales rise even higher, resulting in a gross loss of $1.5 million for the quarter. Operating expenses did not fair much better, with the company reporting expenses of $39.6 million for the period, as compared to $31.8 million in the second quarter.

In terms of the breakdown of expenses, general and administrative made up the bulk of expenditures at $18.9 million, while share based payments amounted to $7.9 million and sales and marketing expenses totaled out at $7.2 million. The result, is that it appears the company needs to make some hard decisions as a means of getting its expenditures to manageable levels, and in line with the revenues that it is generating.

The quarter was essentially “saved” as a function of Cronos’ other income, which includes interest income of $3.8 million – roughly equivalent to 33% of the net revenues the company generated during the quarter. The big ticket item here however is the gain on revaluation of derivative liabilities, which amounted to $105.3 million. In layman terms, the company posted a net income due to its share price falling due to these derivative liabilities. Net income for the quarter overall as a result amount to $68.5 million.

Looking to the balance sheet, the firms cash position was relative unchanged, falling to $1,097 million from that of $1,109 million over the course of the quarter. Short term investments declined to $202.8 million from $213.6 million, while accounts receivables climbed to $6.1 million from $3.5 million. Inventory improved slightly as well to $56.4 million, from $53.2 million. Total current assets overall declined to $1,394.0 million from $1,401.9 million.

Liabilities meanwhile fell fairly significantly, a result again of the gain on derivative liabilities. Derivative liabilities fell to $102.7 million overall, down from $205.7 in the prior quarter. Accounts payable meanwhile rose to $39.0 million from $28.3 million. Overall, total current liabilities fell to $142.9 million, from that of $235.2 million over the course of the three month period.

Cronos Group last traded at $5.54 on the Nasdaq.


Information for this briefing was found via Sedar and Cronos Group. The author has no securities or affiliations related to these organizations. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Is This the Most Overlooked Critical Mineral? (+1000% Move) | Guy Bourassa – Scandium Canada

Is Gold Entering a New 15-Year Cycle? | Rob Husband

A 100,000 Ounce Per Year Gold Plan in Utah | Scott Trebilcock — Revival Gold

Recommended

Silver47 Launches 7,000-Meter Hughes Drill Program In Nevada

Advanced Gold Acquires Nevada Property With Historic Production At 1,611 g/t Silver

Related News

CIBC: Cronos Group CEO Switch Up Is “Somewhat Surprising”

This past week, Cronos Group (TSX: CRON) (NASDAQ: CRON) announced that its Board of Directors...

Saturday, September 12, 2020, 01:45:00 PM

Lord Jones! Cronos Group Generates Positive Net Income Thanks to Declining Share Price

This morning Cronos Group (TSX: CRON, NASDAQ: CRON) reported their third quarter results. We organized...

Tuesday, November 12, 2019, 10:32:28 AM

Cronos Group: Canaccord, PI Reiterate Ratings, Adjust Revenue Estimates

Cronos Group (TSX: CRON) (NASDAQ: CRON) reported its second quarter financials on August 6 pre-market,...

Sunday, August 9, 2020, 04:20:00 PM

Cronos Group Posts Another Gross Loss For Q2, Replaces CFO

Cronos Group (TSX: CRON) (NASDAQ: CRON) this morning reported their second quarter financial results. Revenues...

Friday, August 6, 2021, 08:34:51 AM

Is The Medipharm Labs Supply Arrangement The Source Of Cronos’ Late Filings?

Earlier this week, Cronos Group (TSX: CRON) (NASDAQ: CRON) quietly announced that they would delay...

Wednesday, March 4, 2020, 12:12:37 PM